These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16904725)

  • 1. Inhibition of cancer cell growth by cyclin dependent kinase 4 inhibitors synthesized based on the structure of fascaplysin.
    Mahale S; Aubry C; Jenkins PR; Maréchal JD; Sutcliffe MJ; Chaudhuri B
    Bioorg Chem; 2006 Oct; 34(5):287-97. PubMed ID: 16904725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-(Phenylaminomethylene)isoquinoline-1,3(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4).
    Tsou HR; Otteng M; Tran T; Floyd MB; Reich M; Birnberg G; Kutterer K; Ayral-Kaloustian S; Ravi M; Nilakantan R; Grillo M; McGinnis JP; Rabindran SK
    J Med Chem; 2008 Jun; 51(12):3507-25. PubMed ID: 18494457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA224, a non-planar analogue of fascaplysin, inhibits Cdk4 but not Cdk2 and arrests cells at G0/G1 inhibiting pRB phosphorylation.
    Mahale S; Aubry C; James Wilson A; Jenkins PR; Maréchal JD; Sutcliffe MJ; Chaudhuri B
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4272-8. PubMed ID: 16750360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological activity of new CDK4-specific inhibitors, based on fascaplysin.
    Aubry C; Wilson AJ; Jenkins PR; Mahale S; Chaudhuri B; Maréchal JD; Sutcliffe MJ
    Org Biomol Chem; 2006 Mar; 4(5):787-801. PubMed ID: 16493461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors.
    Zhu G; Conner SE; Zhou X; Shih C; Li T; Anderson BD; Brooks HB; Campbell RM; Considine E; Dempsey JA; Faul MM; Ogg C; Patel B; Schultz RM; Spencer CD; Teicher B; Watkins SA
    J Med Chem; 2003 May; 46(11):2027-30. PubMed ID: 12747775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New fascaplysin-based CDK4-specific inhibitors: design, synthesis and biological activity.
    Aubry C; Jenkins PR; Mahale S; Chaudhuri B; Maréchal JD; Sutcliffe MJ
    Chem Commun (Camb); 2004 Aug; (15):1696-7. PubMed ID: 15278142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural product.
    Soni R; Muller L; Furet P; Schoepfer J; Stephan C; Zumstein-Mecker S; Fretz H; Chaudhuri B
    Biochem Biophys Res Commun; 2000 Sep; 275(3):877-84. PubMed ID: 10973815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, crystal structure and biological activity of beta-carboline based selective CDK4-cyclin D1 inhibitors.
    García MD; Wilson AJ; Emmerson DP; Jenkins PR; Mahale S; Chaudhuri B
    Org Biomol Chem; 2006 Dec; 4(24):4478-84. PubMed ID: 17268643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of novel inhibitors of cyclin-dependent kinases.
    Kent LL; Hull-Campbell NE; Lau T; Wu JC; Thompson SA; Nori M
    Biochem Biophys Res Commun; 1999 Jul; 260(3):768-74. PubMed ID: 10403840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel synthetic oleanolic acid derivative with amino acid conjugate suppresses tumour growth by inducing cell cycle arrest.
    Lu XM; Yi HW; Xu JL; Sun Y; Li JX; Cao SX; Xu Q
    J Pharm Pharmacol; 2007 Aug; 59(8):1087-93. PubMed ID: 17725850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative action of cudraflavone B, isolated from Cudrania tricuspidata, through the downregulation of pRb phosphorylation in aortic smooth muscle cell proliferation signaling.
    Kim TJ; Han HJ; Lim Y; Song MC; Kim J; Hong JT; Yoo HS; Pyo MY; Hwang BY; Lee MK; Yun YP
    J Cardiovasc Pharmacol; 2009 Apr; 53(4):341-8. PubMed ID: 19295442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A plant oxylipin, 12-oxo-phytodienoic acid, inhibits proliferation of human breast cancer cells by targeting cyclin D1.
    Altiok N; Mezzadra H; Patel P; Koyuturk M; Altiok S
    Breast Cancer Res Treat; 2008 May; 109(2):315-23. PubMed ID: 17638069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of extracellular signal-related kinase signaling in esculetin induced G1 arrest of human leukemia U937 cells.
    Lee SH; Park C; Jin CY; Kim GY; Moon SK; Hyun JW; Lee WH; Choi BT; Kwon TK; Yoo YH; Choi YH
    Biomed Pharmacother; 2008 Dec; 62(10):723-9. PubMed ID: 18222060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fascaplysin-inspired diindolyls as selective inhibitors of CDK4/cyclin D1.
    Aubry C; Wilson AJ; Emmerson D; Murphy E; Chan YY; Dickens MP; García MD; Jenkins PR; Mahale S; Chaudhuri B
    Bioorg Med Chem; 2009 Aug; 17(16):6073-84. PubMed ID: 19632122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro.
    Gorshtein A; Rubinfeld H; Kendler E; Theodoropoulou M; Cerovac V; Stalla GK; Cohen ZR; Hadani M; Shimon I
    Endocr Relat Cancer; 2009 Sep; 16(3):1017-27. PubMed ID: 19509067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases.
    Zaharevitz DW; Gussio R; Leost M; Senderowicz AM; Lahusen T; Kunick C; Meijer L; Sausville EA
    Cancer Res; 1999 Jun; 59(11):2566-9. PubMed ID: 10363974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of cyclin D1/CDK4 and pRb mediated by PI3K/AKT pathway activation in Pb2+ -induced neuronal death in cultured hippocampal neurons.
    Li C; Xing T; Tang M; Yong W; Yan D; Deng H; Wang H; Wang M; Chen J; Ruan D
    Toxicol Appl Pharmacol; 2008 Jun; 229(3):351-61. PubMed ID: 18353414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities.
    Moon MJ; Lee SK; Lee JW; Song WK; Kim SW; Kim JI; Cho C; Choi SJ; Kim YC
    Bioorg Med Chem; 2006 Jan; 14(1):237-46. PubMed ID: 16182537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute renal failure during sepsis: potential role of cell cycle regulation.
    Yang QH; Liu DW; Long Y; Liu HZ; Chai WZ; Wang XT
    J Infect; 2009 Jun; 58(6):459-64. PubMed ID: 19428114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.